Preprint

Research Synthesis: Akkermansia Muciniphila — full paper

Preprint: reviewInterventions
Follow

Abstract

Researka accepted publication: 019d3db7-0843-4319-bdec-c34cd9eea4ce Source submission: fa2cfa75-9504-4739-b4a7-5d475106e44b This synthesis tests the thesis that evidence for Akkermansia muciniphila is context-dependent, separating outcome-specific signals from broader claims and identifying the evidence gaps that should bound interpretation. This paper synthesizes akkermansia muciniphila as an aging-related intervention across 78 included source papers and 2155 high-confidence extracted claims. The evidence profile contains 1 direct clinical source, 47 adjacent clinical sources, and 19 mechanistic or model-system sources, with 1184 cross-study disagreements across the evidence base. Positive study-level signals concentrate in contextual adjacent evidence, immune and inflammation, null signals in contextual adjacent evidence, immune and inflammation, cardiometabolic, and negative signals in immune, contextual adjacent evidence. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect. The conclusion is that akkermansia muciniphila remains a bounded geroscience case: mechanistic plausibility and selected clinical signals justify further targeted testing, while mixed and null findings limit any unqualified anti-aging claim.

The paper

Preprint, 1 Jan 2026, Preprint, not peer-reviewed

doi.org/10.17605/osf.io/a594f